Literature DB >> 19946708

Further evidences on a new diagnostic approach for monitoring human Leishmania (L.) infantum chagasi infection in Amazonian Brazil.

Fernando Tobias Silveira1, Ralph Lainson, Adelson Alcimar Almeida De Souza, Marliane Batista Campos, Liliane Almeida Carneiro, Luciana Vieira Rego Lima, Patrícia Karla Santos Ramos, Cláudia Maria de Castro Gomes, Marcia Dalastra Laurenti, Carlos Eduardo Pereira Corbett.   

Abstract

This was a prospective study carried out during a period over 2 years (May/2006-September/2008) with a cohort of 1,099 individuals of both genders, aged 1 year old and older, from an endemic area of American visceral leishmaniasis (AVL) in Pará state, Brazil. The object was to analyze the prevalence and incidence of human Leishmania (L.) infantum chagasi infection as well as the dynamics evolution of its clinical-immunological profiles prior identified: (1) asymptomatic infection (AI); (2) symptomatic infection (SI = AVL); (3) sub-clinical oligosymptomatic infection (SOI); (4) sub-clinical resistant infection (SRI) and; (5) indeterminate initial infection (III). The infection diagnosis was performed by using both the indirect fluorescent antibody test and leishmanin skin test with amastigotes and promastigotes antigens of L. (L.) i. chagasi, respectively. A total of 187 cases of infection were recorded in the prevalence (17%), 117 in the final incidence (6.9%), and 304 in the accumulated prevalence (26.7%), which provided the following distribution into the clinical-immunological profiles: AI, 51.6%; III, 22.4%; SRI, 20.1%; SOI, 4.3%; and SI (=AVL), 1.6%. The major finding regarding the dynamics evolution of infection was concerned to III profile, from which the cases of infection evolved to either the resistant profiles, SRI (21 cases, 30.8%) and AI (30 cases, 44.1%), or the susceptible SI (=AVL; 1 case, 1.5%); the latter 16 cases remained as III till the end of the study. These results provided the conclusion that this diagnostic approach may be useful for monitoring human L. (L.) i. chagasi infection in endemic area and preventing the high morbidity of severe AVL cases.

Entities:  

Mesh:

Year:  2009        PMID: 19946708     DOI: 10.1007/s00436-009-1672-x

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  24 in total

1.  Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up.

Authors:  S M Jeronimo; M J Teixeira; A d Sousa; P Thielking; R D Pearson; T G Evans
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

2.  IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis.

Authors:  O Bacellar; A D'oliveira; S Jerônimo; E M Carvalho
Journal:  Cytokine       Date:  2000-08       Impact factor: 3.861

Review 3.  Genetics and visceral leishmaniasis in the Sudan: seeking a link.

Authors:  Jenefer M Blackwell; Hiba S Mohamed; Muntaser E Ibrahim
Journal:  Trends Parasitol       Date:  2004-06

4.  A prospective study on the dynamics of the clinical and immunological evolution of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region.

Authors:  Fernando T Silveira; Ralph Lainson; José Angelo Crescente; Adelson A A de Souza; Marliane B Campos; Claudia M C Gomes; Márcia D Laurenti; Carlos E P Corbett
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-06-09       Impact factor: 2.184

Review 5.  Lutzomyia longipalpis and the eco-epidemiology of American visceral leishmaniasis, with particular reference to Brazil: a review.

Authors:  Ralph Lainson; Elizabeth F Rangel
Journal:  Mem Inst Oswaldo Cruz       Date:  2006-01-20       Impact factor: 2.743

6.  Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil.

Authors:  S E Jamieson; E N Miller; C S Peacock; M Fakiola; M E Wilson; A Bales-Holst; M-A Shaw; F Silveira; J J Shaw; S M Jeronimo; J M Blackwell
Journal:  Genes Immun       Date:  2006-11-23       Impact factor: 2.676

7.  New perspectives on a subclinical form of visceral leishmaniasis.

Authors:  R Badaro; T C Jones; E M Carvalho; D Sampaio; S G Reed; A Barral; R Teixeira; W D Johnson
Journal:  J Infect Dis       Date:  1986-12       Impact factor: 5.226

8.  Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections.

Authors:  F T Silveira; R Lainson; J J Shaw; A A De Souza; E A Ishikawa; R R Braga
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Nov-Dec       Impact factor: 2.184

9.  Visceral leishmaniasis in Ethiopia. I. Cross-sectional leishmanin skin test in an endemic locality.

Authors:  A Ali; R W Ashford
Journal:  Ann Trop Med Parasitol       Date:  1993-04

10.  Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.

Authors:  V Vinhas; M Freire; O Bacellar; S Cunha; H Rocha; E M Carvalho
Journal:  Braz J Med Biol Res       Date:  1994-05       Impact factor: 2.590

View more
  5 in total

1.  Preclinical diagnosis of American visceral leishmaniasis during early onset of human Leishmania (L.) infantum chagasi-infection.

Authors:  Luciana Vieira do Rêgo Lima; Patrícia Karla Santos Ramos; Marliane Batista Campos; Thiago Vasconcelos dos Santos; Claudia Maria de Castro Gomes; Márcia Dalastra Laurenti; Carlos Eduardo Pereira Corbett; Fernando Tobias Silveira
Journal:  Pathog Glob Health       Date:  2014-12-09       Impact factor: 2.894

2.  Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection.

Authors:  Patrícia Karla Ramos; Karina Inácio Carvalho; Daniela Santoro Rosa; Ana Paula Rodrigues; Luciana Vieira Lima; Marliane Batista Campos; Claudia Maria C Gomes; Márcia Dalastra Laurenti; Carlos Eduardo Corbett; Fernando Tobias Silveira
Journal:  Biomed Res Int       Date:  2016-03-08       Impact factor: 3.411

3.  New record of preclinical diagnosis of American visceral leishmaniasis in Amazonian Brazil encourages optimizing disease control.

Authors:  Luciana Lima; Thiago Vasconcelos-Dos-Santos; Marliane Campos; Patrícia Karla Ramos; Claudia Gomes; Marcia Laurenti; Vania da Matta; Carlos Corbett; Fernando Silveira
Journal:  Parasite Epidemiol Control       Date:  2020-05-08

Review 4.  Risk factors for adverse prognosis and death in American visceral leishmaniasis: a meta-analysis.

Authors:  Vinícius Silva Belo; Claudio José Struchiner; David Soeiro Barbosa; Bruno Warlley Leandro Nascimento; Marco Aurélio Pereira Horta; Eduardo Sérgio da Silva; Guilherme Loureiro Werneck
Journal:  PLoS Negl Trop Dis       Date:  2014-07-24

5.  Are opossums a relevant factor associated with asymptomatic Leishmania infection in the outskirts of the largest Brazilian cities?

Authors:  César Omar Carranza-Tamayo; Guilherme Loureiro Werneck; Gustavo Adolfo Sierra Romero
Journal:  Braz J Infect Dis       Date:  2016-02-08       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.